您的购物车当前为空
别名 贝达喹啉, TMC207, R207910
Bedaquiline (R207910) 是一种二芳基喹啉药物,能同时靶向 c-亚基和 ε-亚基,抑制结核分枝杆菌 (Mtb) F1FO-ATP 合酶。它具有解偶联活性和有用于耐多药结核病的潜力。

Bedaquiline (R207910) 是一种二芳基喹啉药物,能同时靶向 c-亚基和 ε-亚基,抑制结核分枝杆菌 (Mtb) F1FO-ATP 合酶。它具有解偶联活性和有用于耐多药结核病的潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 177 | In Stock | |
| 5 mg | ¥ 400 | In Stock | |
| 10 mg | ¥ 580 | In Stock | |
| 25 mg | ¥ 891 | In Stock | |
| 50 mg | ¥ 1,400 | In Stock | |
| 100 mg | ¥ 2,060 | In Stock | |
| 200 mg | ¥ 3,100 | In Stock |
Bedaquiline 相关产品
| 产品描述 | Bedaquiline (R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis. |
| 体外活性 | Bedaquiline抑制TDR M. tuberculosis菌株的生长,其最小抑菌浓度(MIC)值在0.125至0.5 mg/L之间[1]。在缓慢生长的分枝杆菌(SGM)中,Bedaquiline对抗Mycobacterium avium的活性最高,其MIC50和MIC90值分别为0.03 mg/L和16 mg/L。对于快速生长的分枝杆菌(RGM),Mycobacterium abscessus subsp. abscessus(M. abscessus)和Mycobacterium abscessus subsp. massiliense(M. massiliense)对Bedaquiline的敏感性似乎高于Mycobacterium fortuitum,两种菌种的MIC50和MIC90值分别为0.13 mg/L和>16 mg/L。Bedaquiline还对非结核分枝杆菌(NTM)种显示出中等体外活性[2]。Bedaquiline对于包括耐多药的Mycobacterium tuberculosis在内的Mycobacterium tuberculosis表现出优异的体外活性[3]。 |
| 别名 | 贝达喹啉, TMC207, R207910 |
| 分子量 | 555.5 |
| 分子式 | C32H31BrN2O2 |
| CAS No. | 843663-66-1 |
| Smiles | COC1=NC2=C(C=C(C=C2)Br)C=C1[C@@H](C3=CC=CC=C3)[C@](O)(C4=CC=CC5=C4C=CC=C5)CCN(C)C |
| 密度 | 1.322 g/cm3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 5.56 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容